Mortality rates of testis cancer among US whites declined 34% between 1973 and 1978. The change is attributable to improved therapy for patients with disseminated testis cancer other than seminoma. Thirty-month survival rates among these patients increased from 22% in 1973 to 1976 to 56% in 1977 to 1979 in nine geographic areas monitored by the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.
Li FP, Connelly RR, Myers M. Improved Survival Rates Among Testis Cancer Patients in the United States. JAMA. 1982;247(6):825–826. doi:10.1001/jama.1982.03320310073040
Customize your JAMA Network experience by selecting one or more topics from the list below.